References
- ESHRE Capri Workshop GroupEurope the continent with the lowest fertilityHum Reprod Update201016659060220603286
- AghssaMMAzargoonARamezanzadehFBagheriMA comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cyclesFertil Steril20089041043104818053995
- DomarAGordonKGarcia-VelascoJLa MarcaABarrierePBeligottiFUnderstanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countriesHum Reprod20122741073107922313869
- BoivinJDomarADShapiroDBWischmannTHFauserBCVerhaakCTackling burden in ART: an integrated approach for medical staffHum Reprod201227494195022258661
- PorterRKisselCSaundersHKeckCPatient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pensCurr Med Res Opin200824372773518230195
- HovattaOMcVeighELassAHomburgRNorthern Europe Gonal-f Pre-Filled Pen PMS GroupA large Northern European observational study of follitropin alpha filled-by-mass pre-filled penReprod Biomed Online200918450250819400991
- WelckerJTNawrothFBilgerWPatient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational studyReprod Biol Endocrinol20108111120843323
- AbbottsCSalgado-BragaCAudibert-GrosCA redesigned follitropin alfa pen injector for infertility: results of a market research studyPatient Prefer Adherence2011531533121792303
- UtsunomiyaTTanakaATatsumiKEzcurraDA questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administrationReprod Biol Endocrinol20121019323167906
- IllingworthPJLahoudRQuinnFChidwickKWilkinsonCSacksGSingle-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatmentPatient Prefer Adherence2014881324940048
- van den WijngaardLRodijkICvan der VeenFPatient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experimentHum Reprod201530233133725432926
- SedbonEWainerRPervesCQuality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in FranceReprod Biomed Online200612329830316569316
- WeissNGonadotrophin products: empowering patients to choose the product that meets their needsReprod Biomed Online2007151313717623531
- LandfeldtEJablonowskaBNorlanderEPatient preferences for characteristics differentiating ovarian stimulation treatmentsHum Reprod201227376076922240210
- BühlerKManaging infertility with the follitropin alfa prefilled pen injector – patient considerationsTher Clin Risk Manag20151199526170678
- SchertzJCSaundersHHeckerCLangBArriagadaPThe redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testingExpert Opin Drug Deliv2011891111112021843107
- PalumboAde La FuentePRodríguezMWillingness to pay and conjoint analysis to determine women’s preferences for ovarian stimulating hormones in the treatment of infertility in SpainHum Reprod20112671790179821558333
- PatilMGonadotrophins: the futureJ Hum Reprod Sci20147423624825624659
- SaundersHSchertzJCHeckerCLangBArriagadaPThe recombinant human chorionic gonadotropin prefilled pen: results of patient and nurse human factors usability testingExpert Opin Drug Deliv20129889390022703331